Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2018 / Article

Research Article | Open Access

Volume 2018 |Article ID 3060525 | 14 pages | https://doi.org/10.1155/2018/3060525

Equisetum arvense L. Extract Induces Antibacterial Activity and Modulates Oxidative Stress, Inflammation, and Apoptosis in Endothelial Vascular Cells Exposed to Hyperosmotic Stress

Academic Editor: Hassan Obied
Received12 Sep 2017
Revised09 Nov 2017
Accepted01 Jan 2018
Published14 Feb 2018


Background. The antimicrobial activity of the Equisetum arvense L. extract and the mechanisms involved in the in vitro effects on endothelial vascular cells exposed to hyperosmotic stress were evaluated. Methods. Antimicrobial activity was evaluated by disk diffusion method and minimum inhibitory concentration (MIC) determination, and oxidative stress, inflammation, and apoptosis, in pretreatment with Equisetum arvense L., caffeic acid, and cathechin, were quantified. Results. The results have shown that Equisetum arvense L. exhibited antibacterial effects only on pathogenic gram-positive cocci. The modulatory activity of Equisetum arvense L. on endothelial cells exposed to hypertonic medium was different and depended on the concentration used. Low concentrations of tested compounds exerted antioxidant effect and diminished the activity of caspase-8 and also increased IκB expression while in high doses, Equisetum arvense L. was prooxidant, induced apoptosis, and decreased IL-6 secretion. Conclusions. These experimental findings suggest that Equisetum arvense L. has antibacterial effects on gram-positive cocci and, administered in low dose, may be a new therapeutic approach for diseases associated with hypertonic conditions or oxidative stress and apoptosis.

1. Introduction

Worldwide, research in the past decades has shown an increased interest in the phytochemical products and plant extracts, due to frequent use in the prevention and treatment of some diseases. Several studies have demonstrated that the antioxidants found in plants are of major interest to medicine, owing to the fact that they protect the organism against oxidative stress, generated in the context of some diseases: atherosclerosis, ischemic cardiac disease, cancer, Alzheimer disease, Parkinson disease, aging, and even in infectious diseases [1]. Experimental data have shown that polyphenols can offer an indirect protection by activating the antioxidant transcription through antioxidant-responsive elements (AREs) from the promoter regions of the genes induced by oxidative stress [2]. In addition, polyphenols can modulate the cell signaling involved in cell proliferation [3] and cell cycle progression [4] while also inhibiting inflammation and promoting the apoptosis of damaged cells [5].

Equisetum arvense L (field horsetail) is a perennial fern from the Equisetaceae family. It has a yellowish nonphotosynthetic spore-bearing fertile stem, produced in early spring. The green, photosynthetic, heavily branched sterile stems are produced in late spring and persist to late autumn. The sterile stem is the medicinal product of the plant (Equiseti herba) mentioned in European Pharmacopeia (Ph. Eur. 8) [6]. The most widely known phytochemical compounds of Equisetum arvense L. are flavonoids, phenolic acids, alkaloids, phytosterols, tannins, and triterpenoids [7].

Several studies have described different biological effects of Equisetum arvense L. extract or tea with natural extract, such as antioxidant, anti-inflammatory, antibacterial, antifungal, vasorelaxant, neuro and cardio protectors [8, 9], and antiproliferative properties [7, 10].

Cardiovascular diseases are a leading health problem worldwide [11]. 31% of all deaths are caused by cardiovascular conditions and over 75% of deaths in low-income and middle-income countries can be accredited to heart disease [12]. High salt intake, obesity, aging, impaired glucose tolerance, and diabetes are just some of the factors that correlate positive with inflammation, coagulations alterations, and elevated of extracellular fluid osmolarity found in cardiovascular diseases. In the center of these processes, the microlesion of vascular endothelium under the influence of smoking, hypertension, hyperlipidemia, hyperglycemia, hyperlipoproteinemia, hyperhomocysteinemia, and so forth [13, 14] is the key factor. The vascular endothelial dysfunction is characterized by loss of physiological function such as vasodilation, fibrinolysis, and antiplatelet activity [15]. An imbalance of the factors responsible for modulating vascular tone appears especially with reduced synthesis and release of nitric oxide (NO) with impaired vasodilation and an increase in angiotensin II and endothelin levels, with the onset of abnormal vasoconstriction.

An increased extracellular osmolarity has many negative effects on the endothelium: promotes water flux out of the cells, triggers cell shrinkage and intracellular dehydration [16], increases oxidative stress, and affects protein structure and function in particular enzyme activity with consequences on the structure of the cytoskeleton and nucleus [17]. DNA lesions trigger activation of growth arrest and DNA damage-inducible genes including p53 [17] and promote the apoptosis, according to the degree of osmotic imbalance.

In order to equalize the intracellular and extracellular pressure, the cells develop an adaptive response to osmotic stress by induction of genes responsible for synthesis and transports of “compatible osmolytes.” Many of them, such as heat shock protein, antioxidant enzymes, and adhesion molecules, are required for preserving the protein structure and function [18] and for increasing the protein stability [17]. Moreover, as a response to hyperosmotic stress, the cells express the nuclear factor of the activated T cells-5 (NFAT5), a member of the nuclear transcription factor- (NF-) κB/Rel family of transcription factors, and stimulate the releasing of proinflammatory cytokines [19] such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) by the activated macrophages, T-lymphocytes, smooth muscle cells, and endothelial cells. Reactive oxygen species (ROS) are highly reactive molecules which cause, on one hand, lipid peroxidation, DNA damage, and protein oxidation [20] and, on the other hand, activate stress-activated protein kinases (ERK), protein kinase B, or Akt kinases and NF-κB.

The study of the cytotoxicity and antimicrobial activity of plant extracts is important for their clinical application in medical practice. Bacterial infections, especially those that form biofilm or are associated with antibiotic failure, require the finding of agents with complementary action or synergic effect with antibiotherapy. Staphylococcus aureus is known as an etiologic agent for many skin and mucous infections, especially those caused by methicillin-resistant S. aureus (MRSA) at immunocompromised patients or postoperative [21]. E. coli is frequently described as a cause of chronic and recurrent urinary infection [22] while C. albicans is the most pathogenic species in humans, isolated from biofilms formed on implanted medical devices [23] or is involved in oral candidiasis, both in adult and in children [24]. Several studies have shown that polyphenols from plants can be an alternative to antibiotics against microbial pathogens [2527].

Starting from the previously obtained results, we aimed to test Equisetum arvense L. extract for its antimicrobial activity and for anti-inflammatory, antioxidant, and antiapoptotic properties on endothelial cell cultures. The plant used comes from nonpolluted areas of Bihor County, the harvest time being the months of April and May, when we obtained the highest values of phenolic compound concentration. The effect against gram positive, gram negative, and Candida albicans by disc diffusion test and minimum inhibitory concentration (MIC) was evaluated. Oxidative/antioxidative status and inflammatory status in addition with caspase-3 and 8 activities and their interaction with two doses of Equisetum arvense L. extract, on osmotic stress in vitro, were investigated.

2. Material and Methods

2.1. Plant Collection and Sample Preparation

In our previous research, the plant collection and sample preparation were described [28]. Thus, the sterile stems of Equisetum arvense L. collected in May 2015 (Bihor County) was dried at 40°C, for 96 h, and used for preparation of lyophilized extracts. The extraction of 10 g of sterile stems was made with 100 ml 70% aqueous ethanol for 20 minutes. After centrifugation (10 minutes, 3000), the extract was evaporated to dryness and then was transferred to a sample via lyophilized extract. Shimadzu SCL-POA reversed-phase high-performance liquid chromatography (HPLC) system consisted of a LC-10ADVP pump equipped with SPD-10AVP Diode Array detector was used to assay compositions of phenolic compounds. The column Kintex 5u RPC 18 and mobile phase composed of 0.05% formic acid and 0.05% formic acid-acetonitrile (50 : 50 v/v) were used. The antioxidant activity was evaluated by CUPRAC assay, DPPH method, and FRAPS method. Total polyphenol content was determined with the Folin–Ciocalteu method.

2.2. Chemicals

2-Thiobarbituric acid and Bradford reagent were obtained from Merck KGaA (Darmstadt, Germany), while absolute ethanol and n-butanol were purchased from Chimopar (Bucharest, Romania). ELISA tests for evaluation of caspase-3, caspase-8, IL-6, and TNF-α were obtained from R&D Systems (Minneapolis, MN, USA). NF-κB, phospho-NF-κB p65 (Ser 536), (93H1), IκBα, and phospho-IκBα (Ser 32/36) were purchased from Cell Signaling Technology Inc., Danvers, USA.

2.3. The Antimicrobial Activity

Antimicrobial activity of Equisetum arvense L. was evaluated by disk diffusion method using the standard methodology [29] and by determination of minimum inhibitory concentrations (MICs).

2.3.1. Microorganisms

In our study, we used the following test organisms: reference microbial strains—Staphylococcus aureus (ATCC 29213), Streptococcus pneumoniae (ATCC 49619), Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), and Candida albicans (ATCC 90029) (Microbiologics, USA) and human clinical isolates—Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus agalactiae, and group G beta-hemolytic streptococcus.

2.3.2. Disc Diffusion Test

For staphylococci, Escherichia coli, and Pseudomonas aeruginosa isolates, Mueller-Hinton Agar (Oxoid) was used and for streptococcal strains, Mueller-Hinton 2 agar + 5% sheep blood (BioMerieux). Candida albicans was plated onto Sabouraud Gentamicin Chloramphenicol 2 agar (BioMerieux).

Inoculums were prepared by direct colony suspension in salina from 20–24 h growth from Columbia agar + 5% sheep blood (Biomeriex) for bacterial strains and from Sabouraud Gentamicin Chloramphenicol 2 agar (BioMerieux) for Candida albicans, equivalent to a 0.5 McFarland standard. Each strain was plated onto the appropriate culture media with a sterile cotton swab, and plates were dried for 10–15 minutes. Sterile filter paper discs of 6 mm diameter (HiMedia Laboratories) saturated with 20 μl of Equisetum arvense L. extract were placed onto inoculated plates. After overnight incubation, at 37°C, inhibition zone diameters were measured in millimeters. Filter papers impregnated with distilled water (20 μl) were used as negative controls, and penicillin (10 U, Oxoid), vancomycin discs (30 μg; Oxoid), ofloxacin discs (5 μg; Oxoid), meropenem discs (10 μg; Oxoid), and fluconazole (25 μg; BD BBL) were used as positive controls. Each test was performed in triplicate and mean values were selected.

2.3.3. Minimum Inhibitory Concentration (MIC) Determinations

The MIC is defined as the lowest concentration of a drug that will inhibit the visible growth of an organism after overnight incubation. We used Broth dilution MIC’s—macrodilution for the following test organisms: reference microbial strain—Staphylococcus aureus (ATCC 29213), Streptococcus pneumoniae (ATCC 49619), Streptococcus pyogenes group A (ATCC®12384™ Culti-Loops™) and human clinical isolates—group G beta-hemolytic streptococcus and Staphylococcus aureus. For staphylococci isolates, Mueller-Hinton Broth (Oxoid) was used and for streptococcal strains, Mueler-Hinton Broth plus 5% sheep blood (BioMerieux). We used 75 × 12 mm sterile capped tubes, in two rows for each microbial strain to cover the range of Equisetum arvense L. The first tube, an inoculated tube, controlled the adequacy of the broth to support the growth of the organism, while the second tube was used to check the sterility (an uninoculated tube).

From 200 mg/ml Equisetum arvense L. extract, five dilutions were prepared as follows: 100 mg/ml, 50 mg/ml, 25 mg/ml, 12.5 mg/ml, and 6.25 mg/ml. Inoculums were prepared by direct colony suspension in salina from 20–24 hours grown from Columbia gar supplemented with 5% sheep blood (BioMerieux), equivalent to a 0.5 McFarland standard. 0.1 ml inoculum for each tube was used and all the tubes were incubated at 37°C overnight.

2.4. In Vitro Experimental Data
2.4.1. Cell Culture

Commercial human umbilical vein endothelial cells (HUVEC) were bought from the European Collection of Cell Cultures (ECACC, Porton Down, Salisbury, UK) and multiplied in RPMI medium, supplemented with 10% fetal calf serum (FCS), gentamicin 50 μg/ml, and amphotericin 100 μg/ml (Biochrom AG, Berlin, Germany) in a humidified CO2 incubator at 37°C. Cell cultures in the 23rd to 26th passages were used. The analysis of surface markers was performed by flow cytometry (BD FACS Canto II flow cytometer, Becton Dickinson & Company, Franklin Lakes, NJ, USA) and used different monoclonal antibodies (ICAM-1, CD29, CD34, CD73, CD90, and CD105).

Cells seeded at a density of 104/cm2 in cell culture Petri dishes (TPP) were settled for 24 h in medium then exposed for 24 h to either Equisetum arvense L. extract (25 or 2.5 μg/ml), caffeic acid (10 or 1 μg/ml), and cathechin (10 or 1 μg/ml), as positive controls; afterwards, the cells were washed 3 times with PBS and incubated for 24 h either in normotonic (137 mmol/l) or hypertonic conditions (200 mmol/l). Cells were collected by scraping and treated with a lysis buffer containing IGEPAL-Nonidet 1% (Sigma) and 1% protease inhibitor complex (Sigma) in PBS for 1 h, on ice. The protein content was determined by the Bradford method (Bio-Rad, USA). All the experiments were performed in triplicate.

2.4.2. Cell Viability Testing

To explore the cytotoxicity of Equisetum arvense L. extract, the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) method was employed. Human umbilical vein endothelial cells (HUVECs), seeded at a density of 104/well in ELISA 96-well microtitration flat bottom plaques (TPP, Switzerland), were allowed to settle for 24 h in medium, then treated with different concentrations of extract in medium ranging from 6.5 to 5000 μg/ml, for 24 h. Afterwards, the viability assays were performed. The viability testes were done using CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay as indicated by the producer. The optical density values were read at absorbance of 490 nm using an ELISA plate reader (Tecan, Männedorf, Switzerland) for MTS. All the experiments were conducted in triplicate. Untreated cultures exposed to medium were used as controls.

2.4.3. Oxidative Stress Assessment

Lipid peroxides were determined using the fluorimetric method with 2-thiobarbituric acid (TBA) described by Conti et al. [30] and were expressed as malondialdehyde (MDA) equivalents.

2.4.4. Inflammation and Apoptosis

Inflammation was quantified by measurement of IL-6 and TNF-α levels and apoptosis by evaluation of caspase-3 and caspase-8 activities. In addition, the expressions of total NF-κB protein and the active form (phospho-NF-κB), IκB, and phospho-IκB were evaluated by Western blot in cells exposed to low doses of the three compounds used for treatment. IL-6, TNF-α, the human active caspase-3 immunoassay kits, and caspase-8 colorimetric assay kit were purchased from R&D Systems Inc. (USA). Cell extracts were treated as indicated by the producer, readings were done at 450 nm with correction wavelength set at 540 nm, using an ELISA plate reader (Tecan, Switzerland).

For Western blotting, 20 μg protein lysates/lane were separated by electrophoresis on SDS PAGE gels and transferred to polyvinylidene difluoride membranes, using Bio-Rad Mini-PROTEAN system (Bio-Rad). Blots were blocked and then incubated with antibodies against NF-κB, pNF-κB, IκB, and pIκB, then further washed, and incubated with corresponding secondary HRP-linked antibodies (1 : 1500) (Santa Cruz Biotechnology). Proteins were detected using Supersignal West Femto Chemiluminescent substrate (Thermo Fisher Scientific, Rockford IL, USA) and a Gel Doc Imaging system equipped with a XRS camera and Quantity One analysis software (Bio-Rad). GAPDH (Trevigen Biotechnology Gaithersburg, Maryland, USA) was used as a protein loading control (Baldea et al., 2013).

2.5. Statistical Analysis

The statistical significance of the difference between treated and control groups was evaluated with two-way ANOVA, followed by Dunnett’s multiple test using GraphPad Prism version 4.00 for Windows (GraphPad Software, San Diego, California, USA, http://www.graphpad.com). A value < 0.05 was considered statistically significant.

3. Results

3.1. The Antimicrobial Activity

One of the goals of our study was to determine the antimicrobial activity of the Equisetum arvense L. extract obtained from nonpolluted areas of Bihor County. The results regarding the antimicrobial activity of Equisetum arvense L. extract evaluated by disc diffusion test are summarized in Table 1. Equisetum arvense L. extract exhibited an antibacterial effect on gram-positive bacteria except the clinical isolate of Streptococcus agalactiae GBBHS (group B beta-hemolytic streptococcus) and Staphylococcus epidermidis, the last one being a methicilin-resistant strain. Our extract was the most effective against Streptococcus pneumoniae and against the clinical isolate of Streptococcus pyogenes. No antimicrobial activity was found on Candida albicans or on gram-negative bacteria. In MIC determinations, the lowest concentration of Equisetum arvense L. extract, at which there was visible growth, was 25 mg/ml for Staphylococcus aureus (ATCC 29213) and human isolate Staphylococcus aureus and 12.5 mg/ml for streptococcal strains: Streptococcus pneumoniae (ATCC 49619), Streptococcus pyogenes group A, and group G beta-hemolytic Streptococcus. Subcultures on Columbia agar + 5% sheep blood (BioMérieux) from tubes with 25 mg/ml Equisetum arvense L. extract for staphylococci and 12.5 mg/ml for streptococcal were positive. These values represent the MICs. Subcultures from tubes with 50 mg/ml for staphylococci and 25 mg/ml for streptococcal were negative; these values represent the minimum bactericidal concentrations (MBCs).

Zone of growth inhibition (in mm diameter)
ExtractConcStaphylococcus aureus ATCC 25923Streptococcus pneumoniae ATCC 49619E. coli ATCC 25922Pseudomonas aeruginosa ATCC 27853Candida albicans ATCC 90029Streptococcus pyogenesStreptococcus agalactiaeGroup G beta-hemolytic streptococcusStaphylococcus epidermidisStaphylococcus aureus

Equisetum arvense L.100 mg/ml81166696868
Penicillin10 U3026Not testedNot testedNot tested3233342022
Vancomycin30 μg1823Not testedNot testedNot tested222023Not testedNot tested
Ofloxacinμg27183019Not tested1920181624
Meropenem10 μg30312928Not testedNot testedNot testedNot testedNot testedNot tested
Fluconazole25 μgNot testedNot testedNot testedNot tested32Not testedNot testedNot testedNot testedNot tested
Distilled water 6666666666

3.2. The Antioxidant, Anti-Inflammatory, and Antiapoptotic Activities on HUVECs

Surface marker analysis performed by flow cytometry showed the presence of ICAM-1, CD105, CD29, and CD73 thus suggesting that the cells used in experiment exhibit endothelial functional parameters.

The toxicity of the Equisetum arvense L. extract tested on HUVECs did not lead to any significant changes in cell viability even when high doses (5000 μg/ml) were used (Figure 1).

The hypertonic solution has a prooxidant effect on the lipids of endothelial cells, as shown by the increased lipid peroxide levels () in the cells exposed to high concentrations of saline solutions (Figure 2(a)). At a dose of 25 μg/ml, the Equisetum arvense L. extract has a prooxidant effect, increasing the lipid peroxide levels, both in the basic conditions (normotonic solution) and in the hypertonic solutions (). The caffeic acid and cathechin significantly decreased the lipid peroxide levels compared to the extract () (Figure 2(a)). When using lower doses of the same substances, we found that, in normotonic conditions, the lipid peroxide level was not significantly affected by the treatment with Equisetum arvense L. while in hypertonic conditions, the extract had an antioxidant effect, significantly decreasing the lipid peroxidation (). The best protection of endothelial cells against hyperosmotic stress was exerted by the low concentration of cathechin () (Figure 2(b)).

In order to evaluate the extract effect on inflammation, the levels of IL-6, in both intracellular and the growth medium, and TNF-α were quantified (Figures 3(a)3(d)). For assessing the role of the NF-κB pathway activation in inflammation induced by hypertonic conditions and the impact of low doses of natural compounds, Western blot was performed. After treatments, the protein levels of the total NF-κB protein and the active form, pNF-κB, and also IκB and pIκB were estimated.

Intracellular levels of IL-6, evaluated in endothelial cell lysates, significantly increased in hypertonic conditions () (Figures 3(a) and 3(b)). The preadministration of Equisetum arvense L. or caffeic acid and cathechin, in high doses, amplified the increasing of IL-6 secretion in normotonic conditions, in parallel with the generation of oxidative stress (). In hypertonic medium, the pattern is different; the three tested substances had a stronger anti-inflammatory effect (). The lower doses of the three studied compounds had no proinflammatory effects in normal conditions, but caffeic acid and cathechin were proinflammatory under hypertonic conditions. The low dose of Equisetum arvense L. extract had no significant effect on the IL-6 levels in hypertonic medium (). In hypertonic conditions, we registered an increased concentration of IL-6 in the medium compared to the normotonic situation (). The administration of the high dose of Equisetum arvense L. and caffeic acid had no significant effect on the IL-6 levels found in the growth medium () (Figure 3(c)).

On the contrary, the pretreatment with 10 μg/ml of cathechin reduced significantly IL-6 secretion in the medium. The lower doses of Equisetum arvense L., caffeic acid, and cathechin had no effect on IL-6 secretion found in the growth media (Figure 3(d)).

The hypertonic conditions had no significant effect on the TNF-α secretion compared to normotonic medium (Figures 3(e) and 3(f)). The Equisetum arvense L. extract did not influence the TNF-α levels, in both normotonic and hypertonic conditions. The same effect was exerted by cathechin in both environmental situations. Caffeic acid, in high dose, increased the TNF-α protein level in endothelial cell lysates (). The lower doses of the three compounds did not influence significantly the TNF-α secretion in both experimental conditions (Figure 3(f)).

The effects of normotonic/hypertonic medium and natural extract administration on expressions of NF-κB, pNF-κB IκB, and pIκB proteins were evaluated by Western blot analysis (Figure 4(a)). Phosphorylation of p65/Rel A at Ser 536 regulates activation, nuclear localization, protein-protein interaction, and transcriptional activity. The key factor in the NF-κB pathway activation involves Ikappa kinase (IκK) complex, and IκB is an inhibitor which sequesters NFκB dimers in the cytoplasm in an inactive state. In normotonic medium, the treatment with low dose of Equisetum arvense L. extract () and low doses of caffeic acid () and cathechin () diminished the expression of NF-κB compared to controls, in parallel with increasing of IκB expression, especially after cathechin administration () (Figure 4(b)).

In hypertonic conditions, NF-κB level decreased compared to normotonic medium () and increased only after caffeic acid treatment (). In hypertonic medium, all natural compounds used in the experiment increased the expression of IκB, mostly cathechin in low dose (). The best inhibitory effect on IκB activation was noticed in cells exposed to cathechin (), then after Equisetum arvense L. () and caffeic acid () treatments.

The active form of NF-κB represents a modest part of NF-κB protein, both in normotonic and in hypertonic medium, as illustrated in Figure 4(b). Hypertonicity induced a significant increase of pNF-κB protein expression (), effect amplified by cathechin administration () which exerted an inhibitory effect on pIκB (). Equisetum arvense L. and caffeic acid had also a strong inhibitor effect on activation of IκB in hypertonic medium while in normotonic conditions, the same compounds enhanced its expression ( and , resp.).

In our experimental design, the hypertonic medium did not induce apoptosis compared to normotonic conditions (Figure 5). In the normotonic system, preincubation with low dose of cathechin decreased significantly the caspase-3 activity () while in hypertonic medium, the same compound did not influence the enzyme activity (Figure 5(b)). Caffeic acid and cathechin in high doses were proapoptotic and enhanced the activation of enzyme () in hypertonic conditions while the normotonic medium did not change the enzyme activity (Figure 5(a)).

Preadministration of 10 μg/ml of cathechin had an antiapoptotic effect decreasing caspase-8 activity in endothelial cells exposed to normotonic conditions () (Figure 5(c)). Higher doses of Equisetum arvense L., caffeic acid, and cathechin did not influence the caspase-8 activity in hypertonic conditions () but, in lower doses, decreased the caspase-8 activity, especially Equisetum arvense L. and cathechin, and thus the induction of apoptosis in the same conditions () (Figures 5(c) and 5(d)).

4. Discussion

In previous studies, it has been demonstrated that plants, fruits, and vegetables, due to their phytochemicals composition, have antioxidant, antimicrobial, and anti-inflammatory actions and are used in medicine and nutrition including the cosmetic industry [3133]. In our study, the Equisetum arvense L. extract exhibited an antibacterial effect on Streptococcus pneumoniae and the clinical isolate of Streptococcus pyogenes.

Studies over the past decade attested the in vitro antimicrobial activity Equisetum arvense L. extract, but with some conflicting results. Milovanović et al. [34] described an antifungal effect on Candida albicans while in our study, we did not obtain any inhibitor effect on Candida albicans strain. Our results are in agreement with previous findings reported by Uslu et al. [35] and Čanadanović-Brunet et al. [36]. De Oliveira et al. also demonstrated that Equisetum arvense L. extract at a concentration of 50 mg/mL was effective against Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mutans, Candida albicans, Candida tropicalis, and Candida glabrata, microorganisms involved in oral infections [37]. Protective effects of Equisetum arvense L. extract on Staphylococcus aureus and gram-negative bacteria are also described, both in the aqueous and alcoholic extract, with better response in the case of the alcoholic extract [38, 39]. Radulovic et al. [40] stated that a 1 : 10 dilution of the essential oil obtained by hydrodistillation of aerial parts of Equisetum arvense L. was enough for its strong antimicrobial activity against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella enteritidis, and fungi: Aspergillus niger or Candida albicans. The effects were explained by a composition rich in the essential oil of the plant extract which inactivated the microbial adhesion proteins and transport proteins and induced the rupture of the microbial membrane [41]. In addition, the phenolic compounds reduced the ROS generation induced by bacterial lipopolysaccharides or Candida albicans due to trapping free radicals directly or scavenging them through reactions with antioxidant enzymes [42].

However, other studies showed no effect of the aqueous extract on Staphylococcus aureus and Escherichia coli [36, 43]. One of the explanations for these conflicting results could be the extraction parameters used for obtaining the plant extract which influence the chemical content and the biological activities, including the antimicrobial activity, [35] or different content in phenols [44]. From a quantitative point of view, the flavonoids and polyphenols levels were higher in the first months of the plant’s growth (May, June) compared to the harvest period (August, September). During the month of May, the quantity of flavonoids increased up to 0.72% compared to September, when the values decreased to 0.13% [28]. In similar studies, plants coming from other regions have been shown to have a much lower antioxidant activity [45].

In our extract, the total content of polyphenols and flavonoids was high, as it resulted from findings performed with spectrophotometric techniques [28]. Using HPLC techniques, the large quantities of vanillic, caffeic, ferulic, syringic, synaptic, and gallic acids as phenolic acids and quercetin, epicathechin, cathechin, rutin, naringenin, and myricetin as flavonoids [46] were found. These parameters were in agreement with other findings [47]. The results showed also an in vitro strong antioxidant activity of the extracts obtained from the sterile stems of Equisetum arvense L. Using the FRAP technique, the value determined was 84.160 μmol Trolox equivalent/g DW (TE), using CUPRAC technique, 49.2 μmol Trolox equivalent/g DW (TE), and using DPPH method, 87.3% [46].

Osmotic stress is involved as a pathogenetic mechanism in many cardiovascular diseases and is associated with the efflux of water from the cells and shrinking of cells. In this process, the activity of water channels (aquaporins) and electrolyte transporters, and also the accumulation of osmolytes within the cells [48] for protection of proteins and subcellular structures, are involved.

It is known that under severe hypertonic conditions or when the adaptation mechanisms are outdated, the cells enter to apoptosis and die [49]. Moreover, it seems that apoptosis is associated with persistence of cell shrinkage due to inhibition of protein transport in normal cells [50] or deprivation of glutamine, which functions as compatible osmolyte. In our study, the hypertonic conditions increased only oxidative stress and inflammation and did not influence the apoptosis. Practically, the hypertonicity did not increase the caspase activity compared to normotonic medium; one explanation is probably related to the adaptation process to osmotic stress. The dynamic adaptation to hypertonic environment involved a biphasic response, one early, in seconds or minutes, and another late, in hours and days. The reduction of cellular volume is rapidly corrected by the activation of ion transport systems including Na+-K+-2Cl cotransporter, Na+/H+ exchanger, and the Cl/HCO3 exchanger which lead to intracellular accumulation of ions and increasing of cell volume [51]. In the later phase, the synthesis of compatible osmolytes including neutral amino acids, polyols such sorbitol, and also methylamine such as betaine increased and they substituted the inorganic ions and protected the cell from apoptosis [52]. In this process, the major role is played by TonEBP/NFAT5, a transcription factor involved in the transactivation of “osmoprotective genes” including taurine transporter, aldose reductase, betaine/GABA transporter, and myo-inositol transporter [17]. In addition, activating protein- (AP-) 1 induced by JNK and p38 signaling pathways acts as a central switch to convert extracellular signals into genetic responses [53].

Cytoskeletal remodeling, antioxidant response, and unfolded protein response are other important mechanisms of osmoadaptation. In addition, hyperosmotic stress was found to directly induce TNF-α, IL-1β, IL-6, and IL-8 secretion from different cells [19]. In these mechanisms, the activation of protein kinase R (PKR) under hyperosmotic stress and stimulation of NF-κB p65 phosphorylation at serine 536 and consequently the induction of inflammatory NF-κB p65-responsive genes were involved [54]. Moreover, it was demonstrated that protein kinase R directly phosphorylated IκBα. This is an inhibitor which can mask the nuclear localization of NFκB and sequester NFκB dimers in an inactive state in cytoplasm. IκB phosphorylated is then ubiquitinated and degraded by the proteasome, freeing NF-κB to enter the nucleus and induce expression of inflammatory genes [55]. A higher amount of pNF-κB was obtained when cells were exposed to hypertonic medium alone or in association with cathechin administration, suggesting that cathechin addition increased both the total NF-κB protein and its activation. The active form of IκB protein diminished in cells exposed to Equisetum arvense L., caffeic acid, and cathechin in parallel with increasing of IL-6 levels and NF-κB activation, especially after cathechin administration.

In the experiment, the caspase activities were evaluated only at 24 h after incubation in the hypertonic environment, when the whole adaptation process took place. However, at this time, both oxidative stress and inflammation induced by hypertonicity were maintained at an increasing rate compared to normotonic conditions. In general, oxidative stress is caused by the intracellular accumulation of reactive oxygen species (ROS) or a disturbance of the cellular redox state and can cause intracellular proteins, lipids, and DNA damage. ROS have also been implicated as major mediators of stress-induced signaling as a response to various kinds of environmental stress including osmotic stress. In hyperosmotic stress, the activation of membrane-associated phospholipase A2 and generation of prostaglandins including arachidonic acid is one of the mechanisms involved in the production of redox misbalancing. Phospholipase A2 activates the NADPH oxidase and increases the superoxide anion formation [56]. In addition, xanthine oxidase, nitric oxide (NO) synthase, and heme oxygenases are other sources of intracellular ROS. Anion superoxide in turn induces the activation of protein tyrosine kinases implicated in the regulation of volume-sensitive osmolyte channels and thus helps to maintain cellular homeostasis [57].

In our study, the low doses of the three compounds reduced the lipid peroxidation and protected the cells against stress induced by hypertonic conditions and diminished the activity of caspase-8 and consequently the apoptosis triggered by extrinsic mechanism. In the same conditions, caffeic acid and cathechin, in low concentrations, increased IL-6 secretion and NF-κB activation and diminished pIκB in cells and did not influence the caspase-3 activity. The high doses of the three substances had the opposite effect on inflammation and oxidative stress. Thus, Equisetum arvense L., cathechin, and caffeic acid exerted prooxidant effect and reduced the IL-6 secretion in cells. In addition, caffeic acid and cathechin in high concentrations induced the secretion of TNF-α in the endothelial cells in parallel with prooxidant and proapoptotic effects suggesting the cellular toxicity of high doses of polyphenols.

The different effect on IL-6 secretion can be explained by double functions of IL-6 in cardiovascular systems. IL-6 is secreted in different cells of cardiovascular structures including macrophages, fibroblasts, and endothelial cells as a response to the exposure to cytokines (IL-1, TNF-α), oxidative stress, and angiotensin II and after vascular injury [58]. IL-6 can activate the target cell through a classical signaling pathway after binding to IL-6 receptor (IL-6R) on the cell surface and also by “trans-signaling” mechanism due to soluble IL-6-IL-6Rα complex. This complex initiates the IL-6 signaling [59] and activates the signal transducer and the activator of transcription (STAT) involved in the transcription of target genes. Classic signaling is involved in the activation of anti-inflammatory pathways on target cells while the trans-signaling pathway leads to activation of the immune system by the recruitment of monocytes in the inflamed area and transition from acute to chronic inflammation. It seems that IL-6 suppress the level of proinflammatory cytokines in acute inflammatory response without affecting the secretion of anti-inflammatory cytokines [60].

Our results confirmed the findings of Bessa Pereira et al. [61] regarding the antibacterial effect and Četojević-Simin et al. [7] concerning the antioxidant properties of Equisetum arvense L. extract. The anti-inflammatory activity of the extract demonstrated by Do Monte et al. [62] in wounds and arthritis confirmed the multiple valences of this natural compound.

5. Conclusions

Equisetum arvense L. extract exhibited antibacterial effects on pathogenic gram-positive cocci but had no effect on gram-negative bacteria and Candida albicans. The three compounds tested exert the antioxidant activity and diminished the activity of caspase-8 only in low concentrations, protecting the cells exposed to hyperosmotic stress. In high doses, Equisetum arvense L., cathechin, and caffeic acid had prooxidant effects, induced apoptosis, and decreased IL-6 secretion.

The modulatory effects of Equisetum arvense L. extract on endothelial cells exposed to hypertonic medium are different and depend on the concentration used. These experimental findings suggest that Equisetum arvense L. administered in low doses may be a new therapeutic approach to decrease the enhanced oxidative stress and apoptosis associated with hypertonic conditions. In addition, Equisetum arvense L. extract exhibits antimicrobial activity against gram-positive cocci. However, further more complex studies on different cell lines with multiple doses or exposure times are necessary to prove its clinical potency.

Conflicts of Interest

The authors declare that they have no competing interests.

Authors’ Contributions

Annamaria Pallag, Diana Olteanu, Gabriela Adriana Filip, Ioana Baldea, and Mariana Mureșan conceived and designed the experimental design; Otilia Micle performed the in vitro experiments regarding antimicrobial activity; Diana Olteanu, Ioana Baldea, and Simona Clichici performed the in vitro experiments on cell culture; Eleonora Marian and Laura Vicaș prepared the extract; Otilia Micle, Diana Olteanu, Ioana Baldea, and Gabriela Adriana Filip contributed with the materials; Simona Clichici, Mariana Mureșan, and Eleonora Marian analyzed the data; Annamaria Pallag, Gabriela Adriana Filip, Tunde Jurca, and Mariana Muresan wrote the paper. Annamaria Pallag and Diana Olteanu contributed equally to this work.


The authors would like to give special thanks to Nicoleta Decea for the help with the experiments and to Ioana Robu for the English language assistance.


  1. A. Augustyniak, G. Bartosz, A. Čipak et al., “Natural and synthetic antioxidants: an updated overview,” Free Radical Research, vol. 44, no. 10, pp. 1216–1262, 2010. View at: Publisher Site | Google Scholar
  2. R. Masella, R. Di Benedetto, R. Vari, C. Filesi, and C. Giovannini, “Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes,” The Journal of Nutritional Biochemistry, vol. 16, no. 10, pp. 577–586, 2005. View at: Publisher Site | Google Scholar
  3. G. Corona, M. Deiana, A. Incani, D. Vauzour, M. A. Dessi, and J. P. Spencer, “Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects,” Biochemical and Biophysical Research Communications, vol. 362, no. 3, pp. 606–611, 2007. View at: Publisher Site | Google Scholar
  4. W. Wang, L. Heideman, C. S. Chung, J. C. Pelling, K. J. Koehler, and D. F. Birt, “Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines,” Molecular Carcinogenesis, vol. 28, no. 2, pp. 102–110, 2000. View at: Publisher Site | Google Scholar
  5. L. Fini, E. Hotchkiss, V. Fogliano et al., “Chemopreventive properties of pinoresinol-rich olive oil involve a selective activation of the ATM–p53 cascade in colon cancer cell lines,” Carcinogenesis, vol. 29, no. 1, pp. 139–146, 2008. View at: Publisher Site | Google Scholar
  6. ∗∗∗ European Pharmacopeea, pp. 1121-1122, 8th edition edition, 2014, http://online6.edqm.eu/ep800/.
  7. D. D. Četojević-Simin, J. M. Čanadanović-Brunet, G. M. Bogdanović et al., “Antioxidative and antiproliferative activities of different horsetail (Equisetum arvense L.) extracts,” Journal of Medicinal Food, vol. 13, no. 2, pp. 452–459, 2010. View at: Publisher Site | Google Scholar
  8. J. G. Dos Santos, M. M. Blanco, D. FHM Monte et al., “Sedative and anticonvulsant effects of hydroalcoholic extract of Equisetum arvense,” Fitoterapia, vol. 76, no. 6, pp. 508–513, 2005. View at: Publisher Site | Google Scholar
  9. N. S. Sandhu, S. Kaur, and D. Chopra, “Equisetum arvense: pharmacology and phytochemistry- a review,” Asian Journal of Pharmaceutical Clinical Research, vol. 3, no. 3, pp. 146–150, 2010. View at: Google Scholar
  10. Y. Yamamoto, T. Inoue, and J. Hamako, “Crude proteins extracted from Equisetum arvense L. increases the viability of cancer cells in vivo,” Seibutsu Shiryo Bunseki, vol. 27, no. 5, pp. 409–412, 2004. View at: Google Scholar
  11. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association,” Circulation, vol. 127, no. 1, pp. 143–152, 2013. View at: Publisher Site | Google Scholar
  12. http://www.who.int/cardiovascular_diseases/en.
  13. A. D. Lopez, C. D. Mathers, M. Ezatti, D. T. Jamison, and C. J. Murray, Global Burden of Disease and Risk Factors. In Disease Control Priorities Project, The International Bank for reconstruction and Development/The World Bank, New York, Oxford University Press, Washington, DC, 2006. View at: Publisher Site
  14. D. Hanganu, D. Benedec, L. Vlase et al., “Polyphenolic content and antioxidant activity of Chrysanthemum parthenium extract,” Farmácia, vol. 64, no. 4, pp. 498–501, 2016. View at: Google Scholar
  15. P. Libby, “Inflammation in atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 9, pp. 2045–2051, 2012. View at: Publisher Site | Google Scholar
  16. R. Reinehr and D. Haussinger, “Hyperosmotic activation of the CD95 death receptor system,” Acta Physiologica, vol. 187, no. 1-2, pp. 199–203, 2006. View at: Publisher Site | Google Scholar
  17. M. B. Burg, J. D. Ferraris, and N. I. Dmitrieva, “Cellular response to hyperosmotic stresses,” Physiological Reviews, vol. 87, no. 4, pp. 1441–1474, 2007. View at: Publisher Site | Google Scholar
  18. P. H. Yancey, “Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses,” The Journal of Experimental Biology, vol. 208, no. 15, pp. 2819–2830, 2005. View at: Publisher Site | Google Scholar
  19. L. Schwartz, A. Guais, M. Pooya, and M. Abolhassani, “Is inflammation a consequence of extracellular hyperosmolarity?” Journal of Inflammation, vol. 6, no. 1, p. 21, 2009. View at: Publisher Site | Google Scholar
  20. J. E. Tooke, “Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes,” Journal of Diabetes and its Complications, vol. 14, no. 4, pp. 197–200, 2000. View at: Publisher Site | Google Scholar
  21. S. Lin, S. Melki, M. V. Lisgaris, E. N. Ahadizadeh, and C. A. Zender, “Post-operative MRSA infections in head and neck surgery,” American Journal of Otolaryngology, vol. 38, no. 4, pp. 417–421, 2017. View at: Publisher Site | Google Scholar
  22. L. Emody, M. Kerenyi, and G. Nagy, “Virulence factors of uropathogenic Escherichia coli,” International Journal of Antimicrobial Agents, vol. 22, pp. 29–33, 2003. View at: Publisher Site | Google Scholar
  23. R. M. Donlan, “Biofilm formation: a clinically relevant microbiological process,” Clinical Infectious Diseases, vol. 33, no. 8, pp. 1387–1392, 2001. View at: Publisher Site | Google Scholar
  24. L. M. Schlecht, B. M. Peters, B. P. Krom et al., “Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue,” Microbiology, vol. 161, no. 1, pp. 168–181, 2015. View at: Publisher Site | Google Scholar
  25. R. Gyawali and S. A. Ibrahim, “Natural products as antimicrobial agents,” Food Control, vol. 46, pp. 412–429, 2014. View at: Publisher Site | Google Scholar
  26. P. Su, A. Henriksson, C. Nilsson, and H. Mitchell, “Synergistic effect of green tea extract and probiotics on the pathogenic bacteria, Staphylococcus aureus and Streptococcus pyogenes,” World Journal of Microbiology and Biotechnology, vol. 24, no. 9, pp. 1837–1842, 2008. View at: Publisher Site | Google Scholar
  27. S. Abachi, S. Lee, and R. HPV, “Molecular mechanisms of inhibition of Streptococcus Species by phytochemicals,” Molecules, vol. 21, no. 2, p. 215, 2016. View at: Publisher Site | Google Scholar
  28. A. Pallag, S. Bungau, D. M. Tit et al., “Comparative study of polyphenols, flavonoids and chlorophylls in Equisetum arvense L. populations,” Revista de Chimie, vol. 67, no. 3, pp. 530–533, 2016. View at: Google Scholar
  29. Clinical and Laboratory Standards Institute (CLSI), Performance Standards for Antimicrobial Susceptibility Testing, 26th informational supplement, (CLSI M100–S26 Clinical and Laboratory Standards Institute) CLSI, Wayne (PA), 2016.
  30. M. Conti, P. C. Moran, and P. Levillain, “Improved fluorimetric determination of malondialdehyde,” Clinical Chemistry, vol. 37, no. 7, pp. 1273–1275, 1991. View at: Google Scholar
  31. B. Halliwell, “Food-derived antioxidants: evaluating their importance in food and in vivo,” Food Science and Agricultural Chemistry, vol. 1, pp. 67–109, 1999. View at: Google Scholar
  32. G. K. Jayaprakasha, T. Selvi, and K. K. Sakariah, “Antibacterial and antioxidant activities of grape (Vitis vinifera) seed extracts,” Food Research International, vol. 36, no. 2, pp. 117–122, 2003. View at: Publisher Site | Google Scholar
  33. L. C. Wu, H. W. Hsu, Y. C. Chen, C. C. Chiu, Y. I. Lin, and J. A. Ho, “Antioxidant and antiproliferative activities of red pitaya,” Food Chemistry, vol. 95, no. 2, pp. 319–327, 2006. View at: Publisher Site | Google Scholar
  34. V. Milovanović, N. Radulović, Z. Todorović, M. Stanković, and G. Stojanović, “Antioxidant, antimicrobial and genotoxicity screening of hydro-alcoholic extracts of five Serbian Equisetum species,” Plant Foods for Human Nutrition, vol. 62, no. 3, pp. 113–119, 2007. View at: Publisher Site | Google Scholar
  35. M. E. Uslu, I. Erdogan, O. Bayraktar, and M. Ates, “Optimization of extraction conditions for active components in Equisetum arvense extract,” Romanian Biotechnology Letters, vol. 18, no. 2, pp. 8115–8131, 2013. View at: Google Scholar
  36. J. M. Čanadanović-Brunet, G. S. Ćetković, S. M. Djilas et al., “Radical scavenging and antimicrobial activity of horsetail (Equisetum arvense L.) extracts,” International Journal of Food Science & Technology, vol. 44, no. 2, pp. 269–278, 2009. View at: Publisher Site | Google Scholar
  37. J. R. de Oliveira, V. C. de Castro, P. das Graças Figueiredo Vilela et al., “Cytotoxicity of Brazilian plant extracts against oral microorganisms of interest to dentistry,” BMC Complementary and Alternative Medicine, vol. 13, no. 1, p. 208, 2013. View at: Publisher Site | Google Scholar
  38. R. V. Geetha, T. Lakshmi, and R. Anitha, “In vitro evaluation of anti bacterial activity of Equisetum arvense linn on urinary tract pathogens,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 3, no. 4, p. 323, 2011. View at: Google Scholar
  39. S. Singh, B. K. Sarkar, X. F. Grace, and M. Devgan, “Antimicrobial evaluation of herbal formulation of Equisetum arvense,” European Journal of Biomedical and Pharmaceutical Sciences, vol. 2, no. 3, pp. 908–912, 2015. View at: Google Scholar
  40. N. Radulovic, G. Stojanovic, and R. Palić, “Composition and antimicrobial activity of Equisetum arvense L. essential oil,” Phytotherapy Research, vol. 20, no. 1, pp. 85–88, 2006. View at: Publisher Site | Google Scholar
  41. R. A. S. Alavarce, L. L. Saldanha, N. L. M. Almeida, V. C. Porto, A. L. Dokkedal, and V. S. Lara, “The beneficial effect of Equisetum giganteum L. against Candida biofilm formation: new approaches to denture stomatitis,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 939625, 9 pages, 2015. View at: Publisher Site | Google Scholar
  42. H. Oh, D. H. Kim, J. H. Cho, and Y. C. Kim, “Hepatoprotective and free radical scavenging activities of phenolic petrosins and flavonoids isolated from Equisetum arvense,” Journal of Ethnopharmacology, vol. 95, no. 2-3, pp. 421–424, 2004. View at: Publisher Site | Google Scholar
  43. F. Lotfipour, H. Nazemiyeh, F. Fathi-Azad et al., “Evaluation of antibacterial activities of some medicinal plants from north-west Iran,” Iranian Journal of Basic Medical Sciences, vol. 11, no. 2, pp. 80–85, 2008. View at: Publisher Site | Google Scholar
  44. Z. Kukrić, L. Topalić-Trivunović, S. Pavičić, M. Žabić, S. Matoš, and A. Davidović, “Total phenolic content, antioxidant and antimicrobial activity of Equisetum arvense L,” Chemical Industry and Chemical Engineering Quarterly, vol. 19, no. 1, pp. 37–43, 2013. View at: Publisher Site | Google Scholar
  45. D. Stajner, B. M. Popovic, J. Canadanovic, and P. Boza, “Free radical scavenging activity of three Equisetum species from Fruška Gora mountain,” Fitoterapia, vol. 77, no. 7-8, pp. 601–604, 2006. View at: Publisher Site | Google Scholar
  46. A. Pallag, T. Jurca, B. Pasca, V. Sirbu, A. Honiges, and M. Costuleanu, “Analysis of phenolic compounds composition by HPLC and assessment of antioxidant capacity in Equisetum arvense L. extracts,” Revista de Chimie, vol. 67, no. 8, pp. 1623–1627, 2016. View at: Google Scholar
  47. N. Mimica-Dukic, N. Simin, J. Cvejic, E. Jovin, D. Orcic, and B. Bozin, “Phenolic compounds in field horsetail (Equisetum arvense L.) as natural antioxidants,” Molecules, vol. 13, no. 7, pp. 1455–1464, 2008. View at: Publisher Site | Google Scholar
  48. I. R. Booth and P. Louis, “Managing hypoosmotic stress: aquaporins and medianosensitive channels in Escherichia coli,” Current Opinion in Microbiology, vol. 2, no. 2, pp. 166–169, 1999. View at: Publisher Site | Google Scholar
  49. L. Michea, C. Combs, P. Andrews, N. Dimitreva, and M. B. Burg, “Mitochondrial dysfunction is an early event in high-NaCl-induced apoptosis of mIMCD3 cells,” American Journal of Physiology-Renal Physiology, vol. 282, no. 6, pp. F981–F990, 2002. View at: Publisher Site | Google Scholar
  50. F. Lang, J. Madlung, J. Bock et al., “Inhibition of Jurkat-T-lymphocyte Na+/H+-exchanger by CD95(Fas/Apo-1)-receptor stimulation,” Pflügers Archiv, vol. 440, no. 6, pp. 902–907, 2000. View at: Publisher Site | Google Scholar
  51. M. L. McManus, K. B. Churchwell, and K. Strange, “Regulation of cell volume in health and disease,” The New England Journal of Medicine, vol. 333, no. 19, pp. 1260–1267, 1995. View at: Publisher Site | Google Scholar
  52. R. R. Alfieri, P. G. Petronini, M. A. Bonelli et al., “Osmotic regulation of ATA2 mRNA expression and amino acid transport system A activity,” Biochemical and Biophysical Research Communications, vol. 283, no. 1, pp. 174–178, 2001. View at: Publisher Site | Google Scholar
  53. L. Wang, W. Dai, and L. Lu, “Hyperosmotic stress-induced corneal epithelial cell death through activation of Polo-like kinase 3 and c-Jun,” Investigative Ophthalmology & Visual Science, vol. 52, no. 6, pp. 3200–3206, 2011. View at: Publisher Site | Google Scholar
  54. K. T. Farabaugh, M. Majumder, B. J. Guan et al., “Protein kinase R mediates the inflammatory response induced by hyperosmotic stress,” Molecular and Cellular Biology, vol. 37, no. 4, pp. e00521–e00516, 2017. View at: Publisher Site | Google Scholar
  55. D. E. Nelson, A. E. Ihekwaba, M. Elliott et al., “Oscillations in NF-κB signaling control the dynamics of gene expression,” Science, vol. 306, no. 5696, pp. 704–708, 2004. View at: Publisher Site | Google Scholar
  56. R. J. Aitken, J. K. Wingate, G. N. De Iuliis, A. J. Koppers, and E. A. McLaughlin, “Cis-unsaturated fatty acids stimulate reactive oxygen species generation and lipid peroxidation in human spermatozoa,” The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 10, pp. 4154–4163, 2006. View at: Publisher Site | Google Scholar
  57. I. H. Lambert, S. F. Pedersen, and K. A. Poulsen, “Activation of PLA2 isoforms by cell swelling and ischaemia/hypoxia,” Acta Physiologica, vol. 187, no. 1-2, pp. 75–85, 2006. View at: Publisher Site | Google Scholar
  58. A. R. Brasier, A. Recinos, and M. S. Eledrisi, “Vascular inflammation and the renin-angiotensin system,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 8, pp. 1257–1266, 2002. View at: Publisher Site | Google Scholar
  59. T. D. Vardam, L. Zhou, M. M. Appenheimer et al., “Regulation of a lymphocyte–endothelial–IL-6 trans-signaling axis by fever-range thermal stress: Hot spot of immune surveillance,” Cytokine, vol. 39, no. 1, pp. 84–96, 2007. View at: Publisher Site | Google Scholar
  60. G. Kaplanski, V. Marin, F. Montero-Julian, A. Mantovani, and C. Farnarier, “IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation,” Trends in Immunology, vol. 24, no. 1, pp. 25–29, 2003. View at: Publisher Site | Google Scholar
  61. C. Bessa Pereira, P. S. Gomes, J. Costa-Rodrigues et al., “Equisetum arvense hydromethanolic extracts in bone tissue regeneration: in vitro osteoblastic modulation and antibacterial activity,” Cell Proliferation, vol. 45, no. 4, pp. 386–396, 2012. View at: Publisher Site | Google Scholar
  62. F. H. Do Monte, J. G. dos Santos Jr, M. Russi, V. M. Lanziotti, L. K. Leal, and G. M. Cunha, “Antinociceptive and anti-inflammatory properties of the hydroalcoholic extract of stems from Equisetum arvense L. in mice,” Pharmacological Research, vol. 49, no. 3, pp. 239–243, 2004. View at: Publisher Site | Google Scholar

Copyright © 2018 Annamaria Pallag et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1915 Views | 479 Downloads | 3 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder
 Sign up for content alertsSign up

You are browsing a BETA version of Hindawi.com. Click here to switch back to the original design.